Allan Pamba

VP of Pharmaceuticals, East Africa, GlaxoSmithKline ,
"GSK has fundamentally changed its business from top to bottom to help more patients – wherever they are in the world – get the medicines and vaccines they need. And in doing so, we are showing that it is possible to create value for business and for society."

Dr Pamba works with GlaxoSmithkline (GSK) as VP, Pharmaceuticals, East Africa and Government Affairs, Africa. He is responsible for GSK commercial operations in 9 Eastern Africa countries.  His role is focused on driving sustainable delivery of medicines & vaccines via innovative business models. He leads GSK’s engagement & partnership with governments & other Global Health stakeholders in Africa towards better Healthcare Access.

Dr Pamba is also the Co-Chair of the UN, Every Woman Every Child Innovation Working Group (IWG), a role he shares with Dr Peter Singer. The Innovation Working Group (IWG) was created in 2010 to tap into the potential of innovations that can accelerate progress towards the health MDGs, in support of the Global Strategy for Women's and Children's Health. It is part of the UN secretary general’s Every Woman Every Child Initiative (EWEC).

Prior to GSK, Dr Pamba trained & worked as a physician in Kenya. He worked in clinical care at various levels of health delivery including Government service, rural mission hospitals & research hospitals. He conducted clinical trials on management of severe Malaria in children at the Wellcome-Trust Research Unit in Kilifi Kenya and has published several papers on malaria. Dr Pamba set up one of the first HIV Comprehensive Care Clinics in government service in Kenya benefitting from PEPFAR funding. He has a special interest in equitable access to healthcare & over-all economic & social development in developing countries across Africa & Asia.

Watch Dr. Pamba present at the Shared Value Leadership Summit: Shared Value Storyteller: GlaxoSmithKline

View More Shared Value Thought Leaders»